Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2002
10/03/2002US20020142373 Tissue factor protein variants
10/03/2002US20020142372 Fragments of cr1 and their use
10/03/2002US20020142371 Detecting target polynucleotides in a test sample; obtain sample, incubate with probe, detect signal, presence of signal indicates target sequences
10/03/2002US20020142359 Monoclonal antibody to CEA, conjugates comprising said antibody, and their therapeutic use in an adept system
10/03/2002US20020142358 Antibody for use in the diagnosis, prevention and treatment of infections, multiple sclerosis, arthritis, autoimmune, inflammation and graft versus host disease
10/03/2002US20020142356 Immunoassay for C-reactive protein
10/03/2002US20020142353 Connective tissue growth factor (CTGF) and methods of use
10/03/2002US20020142350 Viral nucleotide sequences for use in the prevention and treatment of viral diseases
10/03/2002US20020142330 Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor
10/03/2002US20020142321 Method for the evolutionary design of biochemical reaction networks
10/03/2002US20020142292 Mammalian genes; related reagents and methods
10/03/2002US20020142286 Ejecting cells from fluid; obtain fluid which contains cells, expose fluid to focus energy projection, recover cells ejected from fluid
10/03/2002US20020142282 Immortalized human keratinocyte cell line
10/03/2002US20020141993 Apoptosis; anticancer agents
10/03/2002US20020141992 Deactivation of collagen receptors
10/03/2002US20020141991 Methods of treating inflammatory disease using antibodies which bind GPR-9-6
10/03/2002US20020141983 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease
10/03/2002US20020141982 Gene therapy methods using bone marrow-derived cells
10/03/2002US20020141981 Materials and methods for treating oncological disease
10/03/2002US20020141978 Retroviral vectors
10/03/2002US20020141977 Immunotherapy based on dendritic cells
10/03/2002US20020141976 Red blood cells covalently bound with polymers
10/03/2002US20020141973 Reducing number of tumor cells
10/03/2002US20020139012 Methods for identifying modulators of N-type ion channel inactivation
10/03/2002CA2692295A1 Combined use of methylol-transfer agents and fas-ligands in the treatment of cancer
10/03/2002CA2664797A1 Cytotoxic factors for modulating cell death
10/03/2002CA2633522A1 Methods for delivering nucleic acid molecules into cells and assessment thereof
10/03/2002CA2452233A1 Method of inducing proliferation of retinal stem cells
10/03/2002CA2443676A1 A novel modulator of non-genomic activity of nuclear receptors (mnar) and uses thereof
10/03/2002CA2442581A1 Efficient methods for isolating functional g-protein coupled receptors and identifying active effectors and efficient methods to isolate proteins involved in olfaction and efficient methods to isolate and identifying active effectors
10/03/2002CA2442325A1 Shellfish protein
10/03/2002CA2442254A1 Site-targeted transformation using amplification vectors
10/03/2002CA2442232A1 Methods and nucleic acids for the analysis of hematopoietic cell proliferative disorders
10/03/2002CA2442089A1 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon
10/03/2002CA2442019A1 Sex-specific selection of sperm from transgenic animals
10/03/2002CA2442010A1 New elongase gene and production of.delta. 9-polyunsaturated fatty acids
10/03/2002CA2441947A1 Human papilloma virus immunoreactive peptides
10/03/2002CA2441910A1 Culture medium for cell growth and transfection
10/03/2002CA2441888A1 Xenograft bone matrix for orthopedic applications
10/03/2002CA2441721A1 Human potassium channel
10/03/2002CA2441706A1 A new essential downstream component of the wingless signalling pathway
10/03/2002CA2441700A1 Polypeptides and nucleic acids for bolekine
10/03/2002CA2441688A1 Compositions and methods useful for hcv infection
10/03/2002CA2441580A1 Coagulation factor vii derivatives
10/03/2002CA2441378A1 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
10/03/2002CA2441287A1 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
10/03/2002CA2440676A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002CA2440378A1 Arrayed transfection method and uses related thereto
10/03/2002CA2439961A1 Human cytokine receptor
10/03/2002CA2439678A1 Uses of opg ligand to modulate immune responses
10/03/2002CA2439096A1 Culture medium for enhanced heterologous protein expression
10/03/2002CA2438206A1 Transporters and ion channels
10/03/2002CA2437203A1 Vegetative growth-specific promoter and genetically modified plants obtained thereby
10/03/2002CA2436922A1 Rice-origin high expression polypeptide chain elongation factor promoter and method of using the same
10/03/2002CA2436340A1 Histidine-rich glycoprotein
10/03/2002CA2436208A1 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor
10/03/2002CA2435894A1 End group activated polymers with oligonucleotide ligands
10/03/2002CA2433458A1 Keratinocyte growth factor-2
10/03/2002CA2425862A1 Cd19-specific redirected immune cells
10/03/2002CA2406527A1 Novel human stras-like protein and nucleic acids encoding the same
10/02/2002EP1245680A1 Gibberellin 2 beta-hydroxylase genes of rice and uses thereof
10/02/2002EP1245676A1 Human monoclonal antibodies against tgf-beta ii receptor and medicinal use thereof
10/02/2002EP1245673A2 Efficient genetic suppressor elements
10/02/2002EP1244916A1 INHIBITION OF $g(b)ARRESTIN MEDIATED EFFECTS PROLONGS AND POTENTIATES OPIOID RECEPTOR-MEDIATED ANALGESIA
10/02/2002EP1244807A1 Il-6 like polynucleotide
10/02/2002EP1244803A2 Veto cells effective in preventing graft rejection and devoid of graft versus host potential
10/02/2002EP1244802A2 Root-specific promoter
10/02/2002EP1244798A2 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors
10/02/2002EP1244797A1 Fusion protein delivery system and uses thereof
10/02/2002EP1244796A2 Transduction of recombinases for inducible gene targeting
10/02/2002EP1244793A2 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same
10/02/2002EP1244791A2 Method for producing 6-0-alpha-d-glucopyranosyl-d-sorbite
10/02/2002EP1244790A2 Nucleic acids encoding polypeptides having chips activity
10/02/2002EP1244789A2 Genes identified as required for proliferation of e. coli
10/02/2002EP1244784A2 Methods and compositions for inhibiting neoplastic cell growth
10/02/2002EP1244780A2 Dna encoding the human serine protease t
10/02/2002EP1244778A2 Human heparanase-related polypeptide and nucleic acid
10/02/2002EP1244776A2 Tetrahydropyrimidine oxygenase gene, polypeptides encoded by said gene and method for producing the same
10/02/2002EP1244775A1 Molecular display on multimeric protein scaffolds derived from the e2 component of the alpha-ketoacid dehydrogenase
10/02/2002EP1244774A2 Pak5 a member of the p21-activated kinase (pak) protein family, nucleic acids and methods related to the same
10/02/2002EP1244773A1 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof
10/02/2002EP1244772A2 Pathologically modified myocardial cell, production and use thereof
10/02/2002EP1244732A1 Novel carrier beads for cell culture bearing particular properties and production thereof
10/02/2002EP1244707A1 Antibodies against signal regulator proteins
10/02/2002EP1244705A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof
10/02/2002EP1244703A1 Novel abcb9 transporter and uses thereof
10/02/2002EP1244701A1 Transferrin polynucleotides, polypeptides, and antibodies
10/02/2002EP1244700A2 Vesicle trafficking proteins
10/02/2002EP1244692A2 Compositions and methods for detecting stress-inducible proteins
10/02/2002EP1244689A2 Cytokine polypeptides and nucleic acids
10/02/2002EP1244686A1 Transforming growth factor alpha hiii
10/02/2002EP1244685A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies
10/02/2002EP1244683A1 21 human secreted proteins
10/02/2002EP1244396A1 Methods and compositions for organ decellularization
10/02/2002EP1244350A2 Prostatic cell line and use thereof to obtain an established prostatic cancer in an animal
10/02/2002EP1244349A2 Pyrophosphatase stress-related proteins and methods of use in plants
10/02/2002EP1131471B1 A system for cell-based screening
10/02/2002EP1077068B9 Utilization of interferon alpha 5 in the treatment of viral hepatopathies
10/02/2002EP0793503B1 Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells
10/02/2002EP0717750B1 Double-stranded peptide nucleic acids
1 ... 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 ... 1827